{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:29:19Z","timestamp":1778588959600,"version":"3.51.4"},"reference-count":49,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>Statin treatment may ameliorate viral infection\u2010induced exacerbations of chronic obstructive pulmonary disease (<jats:styled-content style=\"fixed-case\">COPD<\/jats:styled-content>), which exhibit <jats:styled-content style=\"fixed-case\">Th<\/jats:styled-content>2\u2010type bronchial inflammation. Thymic stromal lymphopoietin (<jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>), a hub cytokine switching on <jats:styled-content style=\"fixed-case\">Th<\/jats:styled-content>2 inflammation, is overproduced in viral and <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>\u2010stimulated bronchial epithelial cells from <jats:styled-content style=\"fixed-case\">COPD<\/jats:styled-content> donors. Hence, <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content> may be causally involved in exacerbations. This study tests the hypothesis that simvastatin inhibits <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>Epithelial cells, obtained by bronchoscopy from <jats:styled-content style=\"fixed-case\">COPD<\/jats:styled-content> (<jats:italic>n<\/jats:italic> = 7) and smoker control (<jats:italic>n<\/jats:italic> = 8) donors, were grown and stimulated with a viral infection and danger signal surrogate, <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content> (10\u2009\u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>). Cells were treated with simvastatin (0.2\u20135\u2009\u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), with or without mevalonate (13\u201326\u2009\u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), or dexamethasone (1\u2009\u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>) before <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>. Cytokine expression and production, and transcription factor (<jats:styled-content style=\"fixed-case\">IRF<\/jats:styled-content>3 and <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>\u2010\u03ba<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>) activation were determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content> induced <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1, <jats:styled-content style=\"fixed-case\">CXCL<\/jats:styled-content>8 and <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b2. <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content> was overproduced in <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>\u2010exposed <jats:styled-content style=\"fixed-case\">COPD<\/jats:styled-content> cells compared with control. Simvastatin, but not dexamethasone, concentration\u2010dependently inhibited <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>. Unexpectedly, simvastatin acted independently of mevalonate and did not affect <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>\u2010\u03ba<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> activation nor did it reduce production of <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1 and <jats:styled-content style=\"fixed-case\">CXCL<\/jats:styled-content>8. Instead, simvastatin inhibited <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">IRF<\/jats:styled-content>3 phosphorylation and generation of <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Implications<\/jats:title><jats:p>Independent of mevalonate and <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>\u2010\u03ba<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>, previously acknowledged anti\u2010inflammatory mechanisms of pleiotropic statins, simvastatin selectively inhibited <jats:styled-content style=\"fixed-case\">dsRNA<\/jats:styled-content>\u2010induced <jats:styled-content style=\"fixed-case\">IRF<\/jats:styled-content>3 activation and production of <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b2 in <jats:styled-content style=\"fixed-case\">COPD<\/jats:styled-content> epithelium. These data provide novel insight into epithelial generation of <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content> and suggest paths to be exploited in drug discovery aimed at inhibiting <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>\u2010induced pulmonary immunopathology.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1476-5381.2012.02131.x","type":"journal-article","created":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T14:05:48Z","timestamp":1344261948000},"page":"363-374","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Selective inhibition by simvastatin of <scp>IRF<\/scp>3 phosphorylation and <scp>TSLP<\/scp> production in <scp>dsRNA<\/scp>\u2010challenged bronchial epithelial cells from <scp>COPD<\/scp> donors"],"prefix":"10.1111","volume":"168","author":[{"given":"Angelica","family":"Brandelius","sequence":"first","affiliation":[{"name":"Department of Experimental Medical Science Lund University  Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Mahmutovic Persson","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science Lund University  Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Calv\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science Lund University  Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Bjermer","sequence":"additional","affiliation":[{"name":"Skane University Hospital  Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl GA","family":"Persson","sequence":"additional","affiliation":[{"name":"Division of Clinical Chemistry and Pharmacology Lund University  Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Andersson","sequence":"additional","affiliation":[{"name":"Skane University Hospital  Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Uller","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science Lund University  Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.160663"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21521"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni0507-481"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2011.06.003"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01731.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2010.10.004"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41384"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000329131"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081370"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1206741"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.000414"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000829"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200910-1488ED"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni921"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030240"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032158"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.04.007"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909883"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.1941.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1901"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.1080"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2805"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2604007"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607305104"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00471.2010"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051745"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2012.04.007"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2626"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.4.1203"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161207779313777"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6910.982"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200506-859OC"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200512-125SF"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00311.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.106757"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/154405910608500608"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.02.035"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni805"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.03.044"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.11-RAI-0395"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03151.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0700-5"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.125930"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00022-07"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041901"},{"key":"e_1_2_8_47_1","first-page":"13","article-title":"The nature and causes of chronic obstructive pulmonary disease: a historical perspective. The Christie Lecture 2007, Chicago, USA","volume":"16","author":"Warren CP","year":"2009","journal-title":"Can Respir J"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61382-8"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2790"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100580"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2012.02131.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2012.02131.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T16:13:24Z","timestamp":1694535204000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2012.02131.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.1476-5381.2012.02131.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02131.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]},"assertion":[{"value":"2012-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-07-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}